Vanguard® Rapid Resp 3 helps protect dogs from key pathogens associated
with Canine Infectious Respiratory Disease (CIRD) including Bordetella
bronchiseptica (Bb), canine parainfluenza virus (CPiV), and canine
adenovirus type 2 (CAV-2). Trivalent (Bb, CPiV, CAV-2), Bivalent (Bb,
CPiV) and Monovalent (Bb) options. First approved 1-year duration of
immunity for the Bordetella bronchiseptica fraction. Single-nostril (0.5
ml) respiratory vaccines that make administration fast and comfortable.
Intranasal administration via syringe or syringe-free applicator (to
help avoid accidental injections). For the vaccination of healthy dogs 8
weeks of age and older. Modified live virus, avirulent live culture.